Ligand for enhancing oral and CNS delivery of biological agents

   
   

Provided herein is a novel and useful Ligand comprising a peptide comprising an amino acid sequence of SEQ. ID. NO.:6, an analog, a derivative, or a variant thereof, which increases the absorption of biological agents across the blood brain barrier and the gastrointestinal barrier. As a result, a Ligand of the present invention increases the bioavailability of biological agents administered orally.

Con tal que adjunto esté una novela y un Ligand útil que abarcan un peptide que abarca una secuencia del aminoácido de SEQ. Identificación. NO.:6, un análogo, un derivado, o una variante de eso, que aumenta la absorción de agentes biológicos a través de la barrera del cerebro de la sangre y de la barrera gastrointestinal. Consecuentemente, un Ligand de la actual invención aumenta la biodisponibilidad de los agentes biológicos administrados oral.

 
Web www.patentalert.com

< Albumin fusion proteins

< Acyl sulfonamides as inhibitors of HIV integrase

> N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

> Methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator

~ 00102